BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22572001)

  • 21. Intranasal immunisation with Stx2B-Tir-Stx1B-Zot protein leads to decreased shedding in goats after challenge with Escherichia coli O157:H7.
    Zhang XH; He KW; Zhao PD; Ye Q; Luan XT; Yu ZY; Wen LB; Ni YX; Li B; Wang XM; Guo RL; Zhou JM; Mao AH
    Vet Rec; 2012 Feb; 170(7):178. PubMed ID: 22186381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection.
    Cai K; Gao X; Li T; Wang Q; Hou X; Tu W; Xiao L; Tian M; Liu Y; Wang H
    Vaccine; 2011 Jan; 29(5):946-52. PubMed ID: 21134452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive transfer of antibodies to Shiga toxin-producing Escherichia coli O26, O111 and O157 antigens in neonatal calves by feeding colostrum.
    Widiasih DA; Matsuda I; Omoe K; Hu DL; Sugii S; Shinagawa K
    J Vet Med Sci; 2004 Feb; 66(2):213-5. PubMed ID: 15031554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of hha and hha sepB mutant strains of Escherichia coli O157:H7 as bacterins for reducing E. coli O157:H7 shedding in cattle.
    Sharma VK; Dean-Nystrom EA; Casey TA
    Vaccine; 2011 Jul; 29(31):5078-86. PubMed ID: 21550373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgA and IgG antibody responses following systemic immunization of cattle with native H7 flagellin differ in epitope recognition and capacity to neutralise TLR5 signalling.
    McNeilly TN; Mitchell MC; Nisbet AJ; McAteer S; Erridge C; Inglis NF; Smith DG; Low JC; Gally DL; Huntley JF; Mahajan A
    Vaccine; 2010 Feb; 28(5):1412-21. PubMed ID: 19925908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7.
    Cai K; Tu W; Liu Y; Li T; Wang H
    Sci Rep; 2015 Dec; 5():17479. PubMed ID: 26626573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains.
    Yoshimura K; Matsui T; Itoh K
    Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts (BGs) reduces the excretion of E. coli O157:H7 in calves.
    Vilte DA; Larzábal M; Mayr UB; Garbaccio S; Gammella M; Rabinovitz BC; Delgado F; Meikle V; Cantet RJ; Lubitz P; Lubitz W; Cataldi A; Mercado EC
    Vet Immunol Immunopathol; 2012 Apr; 146(2):169-76. PubMed ID: 22460171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of Shiga-toxin negative Escherichia coli O157 aflagellate and intimin deficient mutants in porcine in vitro and in vivo models of infection.
    Best A; La Ragione RM; Clifford D; Cooley WA; Sayers AR; Woodward MJ
    Vet Microbiol; 2006 Mar; 113(1-2):63-72. PubMed ID: 16337755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.
    Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
    Infect Immun; 2002 Feb; 70(2):612-9. PubMed ID: 11796590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Escherichia coli O157:H7 using chicken immunoglobulin Y.
    Sunwoo HH; Wang WW; Sim JS
    Immunol Lett; 2006 Aug; 106(2):191-3. PubMed ID: 16781781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England.
    Evans J; Chalmers RM; Chart H; Salmon RL; Kench SM; Coleman TJ; Meadows D; Morgan-Capner P; Softley P; Sillis M; Thomas DR
    Eur J Epidemiol; 2000; 16(10):885-9. PubMed ID: 11338118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced faecal shedding of Escherichia coli O157:H7 in cattle following systemic vaccination with γ-intimin C₂₈₀ and EspB proteins.
    Vilte DA; Larzábal M; Garbaccio S; Gammella M; Rabinovitz BC; Elizondo AM; Cantet RJ; Delgado F; Meikle V; Cataldi A; Mercado EC
    Vaccine; 2011 May; 29(23):3962-8. PubMed ID: 21477674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherichia coli O157:H7.
    Lissner R; Schmidit H; Karch H
    Infection; 1996; 24(5):378-83. PubMed ID: 8923050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of concentration and avidity of specific antibodies to E. coli in breast milk and serum.
    Sennhauser FH; Macdonald RA; Roberton DM; Hosking CS
    Immunology; 1989 Mar; 66(3):394-7. PubMed ID: 2649438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal antibody responses of colonized cattle to Escherichia coli O157-secreted proteins, flagellin, outer membrane proteins and lipopolysaccharide.
    Nart P; Holden N; McAteer SP; Wang D; Flockhart AF; Naylor SW; Low JC; Gally DL; Huntley JF
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):59-68. PubMed ID: 17995963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of recombinant antibodies developed for capturing enterohemorrhagic Escherichia coli O157:H7.
    Kanitpun R; Wagner GG; Waghela SD
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):902-12. PubMed ID: 15916089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice.
    Gao X; Cai K; Li T; Wang Q; Hou X; Tian R; Liu H; Tu W; Xiao L; Fang L; Luo S; Liu Y; Wang H
    Vaccine; 2011 Sep; 29(38):6656-63. PubMed ID: 21742003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.
    Mohawk KL; Melton-Celsa AR; Robinson CM; O'Brien AD
    Vaccine; 2010 Jul; 28(30):4777-85. PubMed ID: 20472033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.